+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chemotherapy-induced Thrombocytopenia Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5328063
  • Report
  • December 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Amgen Inc.
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Chemotherapy-induced thrombocytopenia is a serious complication caused by chemotherapy in the cancer patients. Chemotherapy-induced thrombocytopenia is defined as peripheral platelet count less than 100×109/L, with or without bleeding in cancer patients, which is a serious complication that can lead to chemotherapy dose delays, dose reductions, or discontinuation, and increases the risk of serious bleeding events.

Market Dynamics

Rising cancer cases is the major factor that is expected to drive growth of the global chemotherapy-induced thrombocytopenia therapeutics market during the forecast period. For instance, according to the GLOBOCAN 2018, around 1,412,732 new cancer cases and 672,758 cancer deaths occurred in Latin America and the Caribbean in 2018, where prostate cancer in males and breast cancer in females were the leading cause of cancer death in the region. Moreover, according to the Cancer Research UK, 2015 statistics, 55,122 new cases of breast cancer were registered in 2015, in the U.K. and breast cancer was the most common cancer, accounting for 15% of all new cancer cases in 2015.

Market players are focusing on research and development activities for offering novel products for the treatment chemotherapy-induced thrombocytopenia, which is expected to drive the market growth over the forecast period. For instance, in September 2019, Amgen Inc., initiated Phase III trials, in order to study Romiplostim for chemotherapy-induced thrombocytopenia in adult with gastrointestinal, pancreatic, or colorectal cancer. The study is expected to complete in June 2023.

Key features of the study:
  • This report provides in-depth analysis of the global chemotherapy-induced thrombocytopenia therapeutics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global chemotherapy-induced thrombocytopenia therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Amgen Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Janssen Global Services, LLC (Johnson & Johnson), Partner Therapeutics, Inc., Mission Pharmacal Company, Myelo Therapeutics GmbH, Jiangsu HengRui Medicine Co., Ltd., and Dova Pharmaceuticals, Inc. (Swedish Orphan Biovitrum)
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global chemotherapy-induced thrombocytopenia therapeutics market report caters to various stakeholders in this industry including investors, suppliers, chemotherapy-induced thrombocytopenia therapeutics manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global chemotherapy-induced thrombocytopenia therapeutics market.
Detailed Segmentation

Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Drug Class
  • Thrombopoietin Receptor Agonists
  • Thrombopoietic Agents
  • Others
Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Route of Administration
  • Oral
  • Injectable
Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Distribution Channel
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Region
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Amgen Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • Janssen Global Services, LLC (Johnson & Johnson)
  • Partner Therapeutics, Inc.
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Jiangsu HengRui Medicine Co., Ltd.
  • Dova Pharmaceuticals, Inc. (Swedish Orphan)
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • MORE
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Class
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Merger and Acquisition Scenario
  • Market Share Analysis
4. Global Chemotherapy-induced Thrombocytopenia Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic
  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • COVID-19 Impact on the Cancer Treatment
  • COVID-19 Impact on the Chemotherapy
5. Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Drug Class, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Thrombopoietin Receptor Agonists
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Thrombopoietic Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Route of Administration, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Distribution Channel, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
8. Global Chemotherapy-induced Thrombocytopenia Therapeutics Market, By Region, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Drug Class, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016 - 2027 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
9. Competitive Landscape
  • Heat Map Analysis
  • Company Profiles
  • Amgen Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Novartis
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Mylan N.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Janssen Global Services, LLC (Johnson & Johnson)
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Partner Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Mission Pharmacal Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Myelo Therapeutics GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Jiangsu HengRui Medicine Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Dova Pharmaceuticals, Inc. (Swedish Orphan Biovitrum)
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views
10. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • Janssen Global Services, LLC (Johnson & Johnson)
  • Partner Therapeutics, Inc.
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Jiangsu HengRui Medicine Co., Ltd.
  • Dova Pharmaceuticals, Inc. (Swedish Orphan)
Note: Product cover images may vary from those shown
Adroll
adroll